Business news and discussion on TalkFuse.
Applied Nutrition profit surges as weight-loss jabs fuel demand
Applied Nutrition reported sharply higher revenue and profit, saying products aimed at people taking GLP-1 weight-loss medicines helped drive growth. The results show how the rising use of these treatments is creating new demand in the sports nutrition market, even as it pushes up the cost of whey protein, a key ingredient that has squeezed the company’s margins.
Revenue rose by half to £161.6m in the year to the end of July, while pre-tax profit increased 44 per cent to £40.6m. The company said the share of British consumers using weight-loss medication climbed from 3.1 per cent in June last year to 6 per cent in March; its new ranges include protein shakes, creatine, collagen and digestive supplements. Shares have gained 133 per cent since the company’s October 2024 IPO.
In short
- Applied Nutrition revenue rose 50 per cent to £161.6m.
- Pre-tax profit climbed 44 per cent to £40.6m.
- GLP-1 users are a growing market for its supplements.